Cementoblastoma is a benign odontogenic tumor of mesenchymal origin that arises from cementoblasts, comprising 1–6.2% of all odontogenic tumors. Occurs more often in males with a mean age of 20.7 years and the mandible premolar–molar region is the most common site. The most common symptoms are pain and swelling. It has a characteristic radiographic presentation and unlimited growth potential. Histologically, the tumor presents sheets of cementum-like tissue, which may contain a large number of reversal lines with active cementoblasts. It may obliterate PDL, produce root resorption, and fuse with the root of the tooth. The recommended treatment is complete enucleation of the tumor mass with the extraction of the involved tooth. The recurrence rate is 37.1% because of incomplete removal of the tumor; therefore, follow-up should be performed.